The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Millions of people in the U.S. have food allergies or food sensitivities, and undeclared allergens are the most common reason for food recalls, according to the FDA. Food sensitivities can range from ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

The (FDA) has announced several Class 1 recalls, the highest risk level, for various food products sold across multiple ...

The FDA has updated the December recall of some of Cal Yee Farms' products to the highest risk level classification for three ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...